Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Too much Congress is bad for your health

Too much Congress is bad for your health

The FDA has been dragooned into withdrawing most of its proposed rule to regulate ephedra, a dietary supplement, adding to the sorry list of public health setbacks mandated by the Dietary Supplement Health and Education Act (DSHEA) passed by Congress in 1994.

FDA's efforts to limit the use of ephedra date at least to 1997, when the agency proposed limiting the dose of ephedrine alkaloids, the active ingredient, to 8 mg per

Read the full 805 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers